News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

1Bitget UEX Daily | Iran Denies Direct Talks; Oil Price Back Above $100; Nasdaq 100 Rule Change May Open Door for SpaceX (March 31, 2026)2Bitcoin data points to ‘rare’ trading setup for relief rally to $71K3Iran's Potential Blockade of the Strait of Hormuz: Approaching April 6 and Growing Market Anxiety

Buffett's Final Chevron Bet: A Contrarian Play on Energy's Near-Term Strength
101 finance·2026/03/31 23:30

Rivian's unveiling of the R2 might represent the pivotal "Model Y moment" that investors are currently doubting.
101 finance·2026/03/31 23:30



IFGL Refractories Leadership Election: Can Mihir Bajoria Revive the Struggling Profit Performance?
101 finance·2026/03/31 23:27

PNB’s Executive Reshuffle: Diverting Attention From Deep-Rooted Operational Issues and Escalating ESG Concerns
101 finance·2026/03/31 23:27

Adani Agri Fresh Divests Stake to Parent Company—Savvy Investors Shift from Agriculture to Energy Investments
101 finance·2026/03/31 23:27


Exelixis' Zanzalintinib Approval Hinge on December 2026 FDA Decision Fuels Catalyst-Driven Overweight Trade
101 finance·2026/03/31 23:27
Flash
23:35
Miner Ivanhoe lowers production guidance for Congolese copper mine, further impacting copper supplyThe mine’s current 2026 production forecast has been lowered to 290,000–330,000 metric tons, and the 2027 forecast has been lowered to 380,000–420,000 metric tons, both below previous estimates. The company’s Chief Executive Officer Marna Cloete stated that the company will not cut corners in its restoration plan and will focus on long-term stability and performance.
23:23
The Australian Therapeutic Goods Administration has issued a notice stating that the medical technology company Boston Scientific is carrying out a corrective action for its Accolade and Visionist series cardiac pacemakers and has simultaneously released a product safety alert.This action involves specific batches of devices. The company has initiated proactive monitoring and replacement procedures to ensure patient safety. Regulatory authorities recommend that clinicians check the serial numbers of affected devices and promptly communicate with the manufacturer regarding follow-up solutions.
23:22
Nouryon, a global leader in specialty chemicals, recently issued a significant market announcement, stating it will implement a global price increase across its full range of ketone peroxide products.The maximum price adjustment this time can reach up to 30%, and the new pricing policy will officially take effect from April 1, 2026. This strategic price adjustment reflects multiple challenges, including the continued pressure on global supply chains, significantly rising raw material costs, and intensified energy price fluctuations. As a core material for key industries such as composite materials and polymer production, price volatility of ketone peroxides will directly affect the operating cost structure of downstream industrial chains. It is notable that Nouryon is implementing this price adjustment simultaneously worldwide, highlighting the common pressures faced by the global chemical market. It is expected that this move will trigger a chain reaction in related industries such as plastics, coatings, and construction. Enterprises need to assess its impact on production costs in advance and formulate corresponding coping strategies.
News